Grant Listings
Displaying 1 - 10 of 51 results
RFA-DA-23-021 : Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
Release Date: 2022-03-28
Grant Status: open
Due Date: Multiple
  • 2022-08-15
  • 2023-02-14
  • 2023-08-15
  • 2024-02-14
  • 2024-08-13
  • 2025-02-14
Close Date: 2025-02-14
Description
According to the Centers for Disease Control and Prevention (CDC), more than 100,000 deaths from overdose were reported from April 2020 to April 2021 alone. Data shows an increase in overdoses due to
SBIR
BOTH
Department of Health and Human Services
National Institutes of Health
PAR-22-102 : Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
Release Date: 2022-01-21
Grant Status: open
Due Date: Multiple
  • 2022-03-28
  • 2022-12-05
  • 2023-03-27
  • 2023-12-04
  • 2024-03-27
  • 2024-12-04
Close Date: 2024-12-05
Description
Background Currently, there are only three medications (four formulations) approved by the FDA for the treatment of alcohol use disorder (AUD). The need for additional medications to treat those af
STTR
BOTH
Department of Health and Human Services
National Institutes of Health
PAR-21-226 : Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)
Release Date: 2021-04-30
Grant Status: open
Due Date: Multiple
  • 2021-09-06
  • 2022-01-05
  • 2022-04-05
  • 2022-09-05
  • 2023-01-05
  • 2023-04-05
  • 2023-09-05
  • 2024-01-05
  • 2024-04-05
Close Date: 2024-09-06
Description
Many NIH-funded research projects rely on vertebrate and invertebrate animal models to study the basics of biology and physiology, to investigate pathological conditions, to examine disease mechanisms
STTR
BOTH
Department of Health and Human Services
National Institutes of Health
PAR-21-225 : Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)
Release Date: 2021-04-30
Grant Status: open
Due Date: Multiple
  • 2021-09-05
  • 2022-01-05
  • 2022-04-05
  • 2022-09-05
  • 2023-01-05
  • 2023-04-05
  • 2023-09-05
  • 2024-01-05
  • 2024-04-05
  • 2024-09-05
Close Date: 2024-09-06
Description
Many NIH-funded research projects rely on vertebrate and invertebrate animal models to study the basics of biology and physiology, to investigate pathological conditions, to examine disease mechanisms
SBIR
BOTH
Department of Health and Human Services
National Institutes of Health
PAR-21-225 : Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)
Release Date: 2021-04-30
Grant Status: open
Due Date: Multiple
  • 2021-09-06
  • 2022-01-05
  • 2022-04-05
  • 2022-09-05
  • 2023-01-05
  • 2023-04-05
  • 2023-09-05
  • 2024-01-05
  • 2024-04-05
Close Date: 2024-09-06
Description
Many NIH-funded research projects rely on vertebrate and invertebrate animal models to study the basics of biology and physiology, to investigate pathological conditions, to examine disease mechanisms
SBIR
BOTH
Department of Health and Human Services
National Institutes of Health
PAR-21-282 : Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional)
Release Date: 2021-08-20
Grant Status: open
Due Date: Multiple
  • 2021-10-20
  • 2022-02-18
  • 2022-06-20
  • 2022-10-18
  • 2023-02-21
  • 2023-06-20
  • 2023-10-18
  • 2024-02-20
  • 2024-06-20
Close Date: 2024-06-21
Description
Blueprint MedTech The NIH Blueprint for Neuroscience Research is a collaborative framework through which 14 NIH Institutes, Centers and Offices jointly support neuroscience-related research, with t
SBIR
BOTH
Department of Health and Human Services
National Institutes of Health
PAR-21-265 : NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)
Release Date: 2021-07-16
Grant Status: open
Due Date: Multiple
  • 2021-09-05
  • 2022-01-05
  • 2022-04-05
  • 2022-09-05
  • 2023-01-05
  • 2023-04-05
  • 2023-09-05
  • 2024-01-05
  • 2024-04-05
Close Date: 2024-04-06
Description
Purpose NINDS is committed to advancing diagnostics and treatments for people burdened by neurological diseases, and the NINDS Small Business Innovation Research (SBIR) and Small Business Technolog
SBIR
Phase II
Department of Health and Human Services
National Institutes of Health
PAR-21-266 : NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Release Date: 2021-07-16
Grant Status: open
Due Date: Multiple
  • 2021-09-05
  • 2022-01-05
  • 2022-04-05
  • 2022-09-05
  • 2023-01-05
  • 2023-04-05
  • 2023-09-05
  • 2024-01-05
  • 2024-04-05
Close Date: 2024-04-06
Description
Purpose NINDS is committed to advancing diagnostics and treatments for people burdened by neurological diseases, and the NINDS Small Business Innovation Research (SBIR) and Small Business Technolog
SBIR
BOTH
Department of Health and Human Services
National Institutes of Health
PAR-21-162 : Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Release Date: 2021-03-29
Grant Status: open
Due Date: Multiple
  • 2021-08-10
  • 2022-02-09
  • 2022-08-09
  • 2023-02-09
  • 2023-08-09
  • 2024-02-09
Close Date: 2024-04-06
Description
A. Overview Recent advances in biology offer unprecedented opportunities to discover new treatments for nervous system disorders. Biotherapeutic development, however, has inherent complexities with
SBIR
BOTH
Department of Health and Human Services
National Institutes of Health
PAR-21-233 : Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Release Date: 2021-04-23
Grant Status: open
Due Date: Multiple
  • 2021-08-10
  • 2022-02-09
  • 2022-08-09
  • 2023-02-09
  • 2023-08-09
  • 2024-02-09
Close Date: 2024-04-06
Description
A. Overview Recent advances in biology offer unprecedented opportunities to discover new treatments for nervous system disorders. Biotherapeutic development, however, has inherent complexities with
SBIR
BOTH
Department of Health and Human Services
National Institutes of Health

Copyright © Semscio 2021 | All rights reserved